International Journal of Infertility & Fetal Medicine

Register      Login

VOLUME 10 , ISSUE 2 ( May-August, 2019 ) > List of Articles

REVIEW ARTICLE

Genetic Counseling in Reproductive Issues: Emphasis on the Genetic Aspects

Aishwarya P Pargaonkar, Rukmini Talagadadeevi, Venkatachalam D Parvathi

Citation Information : Pargaonkar AP, Talagadadeevi R, Parvathi VD. Genetic Counseling in Reproductive Issues: Emphasis on the Genetic Aspects. Int J Infertil Fetal Med 2019; 10 (2):21-27.

DOI: 10.5005/jp-journals-10016-1182

License: CC BY-NC 4.0

Published Online: 01-08-2020

Copyright Statement:  Copyright © 2019; The Author(s).


Abstract

Aim: To provide information regarding contributing genetic factors and emphasize the importance of genetic counseling in reproductive issues. Background: Genetic counseling is a communication process, where a trained genetic counselor helps educate the client about the genetic background and comprehend the options available to deal with the risks and guides them to choose an appropriate line of action that is relevant in their perspective. A client could be indicated for genetic counseling for reproductive issues such as recurrent spontaneous abortions or infertility (primary and secondary infertility or subfertility). There are various etiological factors responsible for these issues, regarding the pregnancy itself or the environment, but genetic factors are a major cause and account for approximately 5% of pregnancy loss. Conclusion: There is poor awareness and knowledge with regard to the role that genetics plays in reproductive issues, which could cause miscarriages, recurrent abortions, or fertility issues. Obviously, there is a requirement for generalized education of communities and targeted interventions at the primary level itself, but in the clinical setting, it is the responsibility of the genetic counselor to counsel in a nondirective and nonbiased way so that the client has authority to make a decision in complete autonomy. Clinical significance: Out of all the clinically recognized pregnancies, 10–15%, globally, end in a miscarriage and the recurrence risk increases with each consecutive pregnancy loss. Chromosomal abnormalities account for around 50–66% of all miscarriages. Infertility is also a major problem in India and it affects 10–14% of Indian population. In order to clearly understand the causes of reproductive issues in the Indian context, all the above factors need to be further investigated.


PDF Share
  1. Emory University School of Medicine, Department of human genetics, division of medical genetics. Reproductive Genetic Counselling, 2008. https://genetics.emory.edu/documents/resources/FS_036.2_GC%20Repro_AE08.pdf.
  2. Stirrat GM. Recurrent abortion. II. Clinical associations, causes, and management. Lancet 1990;336(8717):728–733. DOI: 10.1016/0140-6736(90)92215-4.
  3. Portnoi MF, Joye N, Van den Akker J, et al. Karyotypes of 1142 couples with recurrent abortion. Obstet Gynecol 1988;72(1):31–34.
  4. Hardy K, Hardy PJ. 1st trimester miscarriage: four decades of study. Transl Pediatr 2015;4(2):189–200.
  5. Kwang-Hyun B. Aberrant gene expression associated with recurrent pregnancy loss. Mol Hum Reprod 2004;10(5):291–297. DOI: 10.1093/molehr/gah049.
  6. Ørstavik KH. Skewed X inactivation in healthy individuals and in different diseases. Acta Paediatr Suppl 2006;95(451):24–29. DOI: 10.1080/08035320600618783.
  7. Franco B, Ballabio A. X-inactivation and human disease: X-linked dominant male-lethal disorders. 2006;16(3):254–259.
  8. Sangha KK, Stephenson MD, Brown CJ, et al. Extremely skewed X- Chromosome inactivation is increased in women with recurrent spontaneous abortions. Am J Hum Genet 1999;65(3):913–917. DOI: 10.1086/302552.
  9. Zetterberg H. Methylenetetrahydrofolate reductase and transcobalamin genetic polymorphisms in human spontaneous abortion: biological and clinical implications. Reprod Biol Endocrinol 2004;2:7. DOI: 10.1186/1477-7827-2-7.
  10. Tay SK, Shanske S, Kaplan P, et al. Association of mutations in SCO2, a cytochrome c oxidase assembly gene, with early fetal lethality. Arch Neurol 2004;61(6):950–952. DOI: 10.1001/archneur.61.6.950.
  11. Koscinski I, ElInati E, Fossard C, et al. DPY19L2 Deletion as a Major Cause of Globozoospermia. Am J Hum Genet 2011;88(3):344–350. DOI: 10.1016/j.ajhg.2011.01.018.
  12. Dada R, Gupta NP, Kucheria GK. Yq Microdeletions—Azoospermia Factor Candidate Genes and Spermatogenic Arrest. J Biomol Tech 2004;15(3):176–183.
  13. Koh E, Sin H-S, Fukushima M, et al. Azoospermia factor and male infertility. Reprod Med Biol 2010;9(3):129–137. DOI: 10.1007/s12522-010-0055-4.
  14. Cavallini G. Male idiopathic oligoasthenoteratozoospermia. Asian J Androl 2006;8(2):143–157. DOI: 10.1111/j.1745-7262.2006.00123.x.
  15. Chen B, Zhang Z, Sun X, et al. Biallelic Mutations in PATL2 Cause Female Infertility Characterized by Oocyte Maturation Arrest. Am J Hum Genet 2017;101(4):609–615. DOI: 10.1016/j.ajhg.2017. 08.018.
  16. Ibitoye RT, Renowden SA, Faulkner HJ, et al. Ovarioleukodystrophy due to EIF2B5 mutations. Pract Neurol 2016;16(6):496–499. DOI: 10.1136/practneurol-2016-001382.
  17. Ziller V, Heilmaier C, Kostev K. Time to pregnancy in sub fertile women in German gynaecological practices: analysis of a representative cohort of more than 60,000 patients. Arch Gynecol Obstet 2015;291(3):657–662. DOI: 10.1007/s00404-014-3449-4.
  18. Hamilton-Fairley D, Taylor A. Anovulation. ABC of sub fertility. BMJ 2003;327(7414):546–549. DOI: 10.1136/bmj.327.7414.546.
  19. Institute of Medicine (US) Conference Committee on Fetal Research and Applications. Washington (DC), 1994. Fetal Research and Applications: A Conference Summary.
  20. Shorr AF. Abortion and fetal tissue research: some ethical concerns. 1994 May-June, Fetal Diagnosis and Therapy. Fetal Diagn Ther 1994;9(3):196–203. DOI: 10.1159/000263931.
  21. National Institute of Health, Office of Extramural Research. NIH Grants policy, October 2018. https://grants.nih.gov/grants/policy/nihgps/html5/section_4/4.1.14_human_fetal_tissue_research.htm.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.